Longitudinal follow-up in adults with severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype): non-invasive fibrosis tests predict liver-related endpoints
M. Fromme (Aachen, Germany), S. Amzou (Aachen, Germany), B. Burbaum (Aachen, Germany), P. Striedl (Salzburg, Austria), M. Mandorfer (Vienna, Austria), M. Pons (Barcelona, Spain), J. Genesca (Barcelona, Spain), M. Miravitlles (Barcelona, Spain), E. Aigner (Salzburg, Austria), C. Trautwein (Aachen, Germany), P. Strnad (Aachen, Germany)
Source: International Congress 2022 – Alpha-1 antitrypsin deficiency and chronic airway obstructive diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Fromme (Aachen, Germany), S. Amzou (Aachen, Germany), B. Burbaum (Aachen, Germany), P. Striedl (Salzburg, Austria), M. Mandorfer (Vienna, Austria), M. Pons (Barcelona, Spain), J. Genesca (Barcelona, Spain), M. Miravitlles (Barcelona, Spain), E. Aigner (Salzburg, Austria), C. Trautwein (Aachen, Germany), P. Strnad (Aachen, Germany). Longitudinal follow-up in adults with severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype): non-invasive fibrosis tests predict liver-related endpoints. 2429
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|